Engineering Immune Organoids to Study Pediatric Cancer
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)
Trial Details
- NCT ID
- NCT05890781
- Phase
- NA
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Cancer Type
- Brain Cancer
- Interventions
- Skin biopsy
- Fresh tumor sample
- Blood sample
- Healthy tissue from the tumor
- Spinal cerebrospinal fluid (SCF)
- Locations (sample)
- Villejuif, France|48.7939,2.35992
- Paris, Île-de-France Region, France|48.85341,2.3488
Key Eligibility Criteria
- Age at diagnosis ≤ 25 years except for patients with malignant gliomas and renal tumors for whom no upper age limit is applied
- Medical suspicion or diagnosis of one of the following diseases, regardless of stage:
- Brain tumors
- Renal tumors
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Brain Cancer Trials on Trialify →